Metropolis Healthcare Ltd
METROPOLIS (NSE)

1,445.40

7,406.52
Proj. ROE (%)
21.43
Proj. P/E (x)
-
Proj EV / EBITDA (x)
21.26
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
1,316.71

Stock View

BUY
Share on
The average score for Metropolis Healthcare Ltd stands at 2 against 4, three months back.

Metropolis Healthcare Limited is an India-based diagnostics company that operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa and the Middle East. The Company has spread its footprint across 20 Indian states and over 210 cities.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
1,727.72
100 DMA ()
1,929.61
200 DMA ()
2,469.92
52 Weeks Range
1,378.05
3,579.90
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity